17.04.2019 • NewschloromethanesDede WillamsNouryon

Nouryon to Lift German Chloromethanes Capacity

Nouryon to Lift German Chloromethanes Output (c) Infraserv
Nouryon to Lift German Chloromethanes Output (c) Infraserv

Nouryon, the former AkzoNobel Specialty Chemicals, will begin construction next month on a project to further increase capacity for chloromethanes at its site in Frankfurt, Germany.

The expansion, due to be completed in 2020, is in reaction to growing demand in the market, the company said. Capacity figures were not disclosed.

AkzoNobel first increased chloromethanes production in Frankfurt in 2017. With the new project, annual output capability of the chloromethane methyl chloride – used in construction materials, silicones, surfactants and pharmaceuticals – will rise by more than 30%.

As well as investing in additional capacity, we will also make substantial upgrades to the facility, which will improve overall supply reliability for our customers and support their growth plans,” said Knut Schwalenberg, managing director Industrial Chemicals at Nouryon.

“We have a leading position in the European chloromethanes market and this is a significant investment to strengthen that,” he added.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.